mifepristone has been researched along with afimoxifene in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gronemeyer, H | 1 |
| Gompel, A; Kuttenn, F; Malet, C; Mauvais-Jarvis, P | 2 |
| Chambon, P; Green, S; Jin, JR; Webster, NJ | 1 |
| Bardon, S; Montcourrier, P; Rochefort, H; Vignon, F | 1 |
| Baulieu, EE; Jung-Testas, I | 1 |
| Daxenbichler, G; Hofstädter, F; Marth, C; Müller-Holzner, E; Zeimet, AG | 1 |
| Gurpide, E; Markiewicz, L | 1 |
| Bagchi, MK; Jeyakumar, M; Petukhov, S; Zhang, X | 1 |
| El Etreby, MF; Lewis, RW; Liang, Y | 1 |
| Barrett, JT; El Etreby, F; Hou, M; Kallab, AM; Liang, Y; Schoenlein, PV | 1 |
| Barrett, JT; Delk, JN; Gaddy, VT; Kallab, AM; Porter, AG; Schoenlein, PV | 1 |
| Barrett, JT; Gaddy, VT; Ganapathy, V; Hou, M; Johnson, M; Kallab, A; Lewis, J; Samaddar, JS; Schoenlein, PV; Thangaraju, M | 1 |
| Dohn, MR; Huang, S; Jackson, WH; LeRoith, D; Marrero, M; Periyasamy-Thandavan, S; Schoenlein, PV; Singer, A; Takhar, S; Thangaraju, M; Welborn, AE | 1 |
| Gajewska, M; Sobolewska, A; Zielniok, K | 1 |
2 review(s) available for mifepristone and afimoxifene
| Article | Year |
|---|---|
Transcription activation by estrogen and progesterone receptors.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Gene Expression Regulation; Humans; Ligands; Mifepristone; Molecular Sequence Data; Phosphorylation; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Regulatory Sequences, Nucleic Acid; Tamoxifen; Transcription Factors; Transcription, Genetic; Zinc Fingers | 1991 |
[Antiestrogens and normal human breast cell proliferation].
Topics: 17-Hydroxysteroid Dehydrogenases; Breast; Cell Division; Estradiol; Estrogen Antagonists; Humans; Mifepristone; Progestins; Promegestone; Receptors, Estrogen; Stereoisomerism; Tamoxifen | 1989 |
14 other study(ies) available for mifepristone and afimoxifene
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Normal breast cells in culture. Effect of estrogens, progestins, and antiestrogens.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast; Cell Division; Cells, Cultured; Epithelial Cells; Estradiol; Estrogens; Humans; In Vitro Techniques; Mifepristone; Progestins; Promegestone; Tamoxifen | 1990 |
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.
Topics: DNA; Estradiol; Estrenes; Estrogen Antagonists; Estrogens; Glucocorticoids; HeLa Cells; Hormones; Humans; Mifepristone; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen; Transcription Factors; Transcription, Genetic; Transfection | 1988 |
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.
Topics: Breast Neoplasms; Cell Survival; Estradiol; Estrenes; Estrogen Antagonists; Female; Humans; Mifepristone; Progestins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1987 |
Anti-steroid action in cultured L-929 mouse fibroblasts.
Topics: Animals; Cell Adhesion; Cell Division; Centrifugation, Density Gradient; Dexamethasone; Estradiol; Estrenes; Estrogen Antagonists; Fibroblasts; Mice; Mifepristone; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen | 1984 |
Effects of sex- and glucocorticoid steroids on breast cancer cells grown as either multicellular tumor spheroids or monolayers.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Spheroids, Cellular; Steroids; Tamoxifen; Tumor Cells, Cultured | 1996 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
Topics: Animals; Binding Sites; Cell Line; Chlorocebus aethiops; Humans; Kidney; Ligands; Mice; Mifepristone; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Peptides; Progesterone; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Steroid; Receptors, Thyroid Hormone; Repressor Proteins; Tamoxifen; Transcription, Genetic; Transcriptional Activation | 1998 |
Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture.
Topics: Animals; Antibodies; Apoptosis; Cell Division; Cell Survival; DNA Fragmentation; Estrogen Antagonists; Hormone Antagonists; Humans; Male; Mannosephosphates; Mice; Mice, Nude; Mifepristone; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |
Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytochromes c; Drug Synergism; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Mifepristone; Receptors, Estrogen; Retinoblastoma Protein; Tamoxifen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation | 2003 |
Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Coloring Agents; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Fulvestrant; G1 Phase; Hormone Antagonists; Humans; Immunoblotting; Mifepristone; Phosphorylation; Receptors, Estrogen; Receptors, Progesterone; Resting Phase, Cell Cycle; Tamoxifen; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Down-Regulation; Estrogen Antagonists; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Retinoblastoma Protein; RNA, Small Interfering; Tamoxifen | 2007 |
Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; MAP Kinase Kinase 1; Membrane Proteins; Mifepristone; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, Estrogen; Tamoxifen | 2012 |
Mechanisms of autophagy induction by sex steroids in bovine mammary epithelial cells.
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Beclin-1; Cattle; Cell Line; Culture Media; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation; Mammary Glands, Animal; Microtubule-Associated Proteins; Mifepristone; Phosphorylation; Progesterone; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tamoxifen | 2017 |